NCT05283330 Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors Status RECRUITING Phase PHASE1
NCT05277688 Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients Status RECRUITING Phase PHASE3
NCT05259540 Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT05255393 Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer Status COMPLETED Phase N/A
NCT05247853 HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV Status COMPLETED Phase N/A
NCT05247619 A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer Status UNKNOWN Phase PHASE2
NCT05238883 A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05236855 Spectroscopy and Artificial Intelligence to Disrupt the Status Quo in Cervical Cancer Screening Status UNKNOWN Phase N/A
NCT05220033 Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05215574 Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05189028 Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer Status RECRUITING Phase PHASE3
NCT05188716 Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer Status COMPLETED Phase N/A
NCT05187338 Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05185713 The Mechanism of Vaginal Flora and Its Metabolites in the Pathogenesis of Cervical Cancer Status UNKNOWN Phase N/A
NCT05179317 Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer Status UNKNOWN Phase PHASE2